S. Ostrowitzki : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (41)
Les plus populaires
Liste
- Liste
- Tableau

1

Use of multispectral magnetic resonance imaging analysis to quantify erosive changes in the hands of patients with rheumatoid arthritis: Short-term and long-term longitudinal studies

Susanne Ostrowitzki, János Rédei, John A. Lynch, Richard A. D. Carano, Souhil Zaim, Yves Miaux, Harry K. Genant

Journal:

Arthritis & Rheumatism

Année:

2004

Langue:

english

Fichier:

PDF, 348 KB

english, 2004

2

Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme

Axel Gossmann, Thomas H. Helbich, Nagato Kuriyama, S. Ostrowitzki, Timothy P.L. Roberts, David M. Shames, N. van Bruggen, Michael F. Wendland, Mark A. Israel, Robert C. Brasch

Journal:

Journal of Magnetic Resonance Imaging

Année:

2002

Langue:

english

Fichier:

PDF, 2.47 MB

english, 2002

3

Assessing tumor angiogenesis using macromolecular MR imaging contrast media

Robert Brasch, Christine Pham, David Shames, Timothy Roberts, Kees Van Dijke, Nick Van Bruggen, Jeffry Mann, Susanne Ostrowitzki, Ostap Melnyk

Journal:

Journal of Magnetic Resonance Imaging

Année:

1997

Langue:

english

Fichier:

PDF, 1.25 MB

english, 1997

4

Comparison of gadopentetate dimeglumine and albumin-(Gd-DTPA)30 for microvessel characterization in an intracranial glioma model

Susanne Ostrowitzki, James Fick, Timothy P. L. Roberts, Michael F. Wendland, Kenneth D. Aldape, Jeffry S. Mann, Mark A. Israel, Robert C. Brasch

Journal:

Journal of Magnetic Resonance Imaging

Année:

1998

Langue:

english

Fichier:

PDF, 960 KB

english, 1998

5

Multispectral analysis of bone lesions in the hands of patients with rheumatoid arthritis

Richard A.D. Carano, John A. Lynch, Janos Redei, Susanne Ostrowitzki, Yves Miaux, Souhil Zaim, David L. White, Charles G. Peterfy, Harry K. Genant

Journal:

Magnetic Resonance Imaging

Année:

2004

Langue:

english

Fichier:

PDF, 386 KB

english, 2004

6

Concurrence of cortex and platelet serotonin2receptor binding characteristics in the individual and the putative regulation by serotonin

S. Ostrowitzki, M. L. Rao, J. Rédei, A. H. Andres

Journal:

Journal of Neural Transmission

Année:

1993

Langue:

english

Fichier:

PDF, 576 KB

english, 1993

7

Arguments Against Precompetitive Collaboration

Vargas, G, Boutouyrie, B, Ostrowitzki, S, Santarelli, L

Journal:

Clinical Pharmacology & Therapeutics

Année:

2010

Langue:

english

Fichier:

PDF, 145 KB

english, 2010

8

Prerequisites to launch neuroprotective trials in Parkinson's disease: An industry perspective

Johannes R. Streffer, Igor D. Grachev, Cheryl Fitzer-Attas, Baltazar Gomez-Mancilla, Babak Boroojerdi, Juliana Bronzova, Susanne Ostrowitzki, Stephen J. Victor, Paulo Fontoura, Robert Alexander

Journal:

Movement Disorders

Année:

2012

Langue:

english

Fichier:

PDF, 722 KB

english, 2012

9

PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders

S. Saenger, C. Goeldner, J.R. Frey, L. Ozmen, S. Ostrowitzki, W. Spooren, T.M. Ballard, E. Prinssen, E. Borroni, F. Metzger

Journal:

Growth Hormone & IGF Research

Année:

2011

Langue:

english

Fichier:

PDF, 1.16 MB

english, 2011

10

Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment

M. Lorenzi, M. Donohue, D. Paternicò, C. Scarpazza, S. Ostrowitzki, O. Blin, E. Irving, G.B. Frisoni

Journal:

Neurobiology of Aging

Année:

2010

Langue:

english

Fichier:

PDF, 1.14 MB

english, 2010

11

Human brain cortex and platelet serotonin2 receptor binding properties and their regulation by endogenous serotonin

Alexander H. Andres, Marie Luise Rao, Susanne Ostrowitzki, Wolfgang Entzian

Journal:

Année:

1993

Langue:

english

Fichier:

PDF, 550 KB

english, 1993

12

Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab

Ostrowitzki, Susanne

Journal:

Archives of Neurology

Année:

2012

Langue:

english

Fichier:

PDF, 868 KB

english, 2012

13

Characterization of [11C]RO5013853, a novel PET tracer for the glycine transporter type 1 (GlyT1) in humans

Wong, Dean F., Ostrowitzki, Susanne, Zhou, Yun, Raymont, Vanessa, Hofmann, Carsten, Borroni, Edilio, Kumar, Anil, Parkar, Nikhat, Brašić, James R., Hilton, John, Dannals, Robert F., Martin-Facklam, Me

Journal:

Année:

2013

Langue:

english

Fichier:

PDF, 1.49 MB

english, 2013

14

Pre-clinical characterization of [11C]R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography

Borroni, Edilio, Zhou, Yun, Ostrowitzki, Susanne, Alberati, Daniela, Kumar, Anil, Hainzl, Dominik, Hartung, Thomas, Hilton, John, Dannals, Robert F., Wong, Dean F.

Journal:

Année:

2013

Langue:

english

Fichier:

PDF, 1.59 MB

english, 2013

15

Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity

Saenger, Stefanie, Holtmann, Bettina, Nilges, Mark R., Schroeder, Susanne, Hoeflich, Andreas, Kletzl, Heidemarie, Spooren, Will, Ostrowitzki, Susanne, Hanania, Taleen, Sendtner, Michael, Metzger, Frie

Journal:

Amyotrophic Lateral Sclerosis

Année:

2012

Langue:

english

Fichier:

PDF, 415 KB

english, 2012

16

Temporal profile of brain response to alprazolam in patients with generalized anxiety disorder

Brown, Gregory G., Ostrowitzki, Susanne, Stein, Murray B., von Kienlin, Markus, Liu, Thomas T., Simmons, Alan, Wierenga, Christina, Stein, Orah Y., Bruns, Andreas, Bischoff-Grethe, Amanda, Paulus, Mar

Journal:

Psychiatry Research: Neuroimaging

Année:

2015

Langue:

english

Fichier:

PDF, 998 KB

english, 2015

17

[11C]-RO5013853: a New PET Radioligand for the Glycine Transporter TYPE 1

Wong, Dean, Ostrowitzki, Susanne, Zhou, Yun, Alberati, Daniela, Pinard, Emmanuel, Raymont, Vanessa, Martin-Facklam, Meret, Hofmann, Carsten, Parkar, Nikhat, Brasic, James, Hilton, John, Dannals, Rober

Journal:

Neuropsychopharmacology

Année:

2014

Langue:

english

Fichier:

PDF, 59 KB

english, 2014

18

Glycine Transporter Type 1 Occupancy by Bitopertin: a Positron Emission Tomography Study in Healthy Volunteers

Martin-Facklam, Meret, Pizzagalli, Flavia, Zhou, Yun, Ostrowitzki, Susanne, Raymont, Vanessa, Brašić, James R, Parkar, Nikhat, Umbricht, Daniel, Dannals, Robert F, Goldwater, Ron, Wong, Dean F

Journal:

Neuropsychopharmacology

Année:

2013

Langue:

english

Fichier:

PDF, 490 KB

english, 2013

19

Frauen in der Ständegesellschaft. Leben und Arbeiten in der Stadt vom späten Mittelalter bis zur Neuzeit (Beiträge zur deutschen und europäischen Geschichte, 4)by Barbara Vogel; Ulrike Weckel

Review by: Anja Ostrowitzki

Journal:

VSWG: Vierteljahrschrift für Sozial- und Wirtschaftsgeschichte

Année:

1992

Langue:

german

Fichier:

PDF, 231 KB

german, 1992

20

Efficacy and safety of gantenerumab in prodromal Alzheimer’s disease: Results from scarlet road—a global, multicenter trial

Lasser, Robert, Ostrowitzki, Susanne, Scheltens, Philip, Boada, Mercè, Dubois, Bruno, Dorflinger, Ernest, Balas, Bogdan, Nikolcheva, Tania, Volz, Dietmar, Ashford, Elizabeth, Edgar, Chris, Garibaldi,

Journal:

Alzheimer's & Dementia

Année:

2015

Langue:

english

Fichier:

PDF, 93 KB

english, 2015

21

Biomarker data from scarlet road: A global phase 3 study of gantenerumab in patients with prodromal Alzheimer's disease

Scheltens, Philip, Nikolcheva, Tania, Lasser, Robert, Ostrowitzki, Susanne, Boada, Mercè, Dubois, Bruno, Dorflinger, Ernest, Volz, Dietmar, Eichenlaub, Udo, Rabe, Christina, Bittner, Tobias, Schmitz,

Journal:

Alzheimer's & Dementia

Année:

2015

Langue:

english

Fichier:

PDF, 65 KB

english, 2015

22

Challenges, solutions, and recommendations for Alzheimer's disease combination therapy

Hendrix, James A., Bateman, Randall J., Brashear, H. Robert, Duggan, Cynthia, Carrillo, Maria C., Bain, Lisa J., DeMattos, Ronald, Katz, Russell G., Ostrowitzki, Susanne, Siemers, Eric, Sperling, Reis

Journal:

Alzheimer's & Dementia

Année:

2016

Langue:

english

Fichier:

PDF, 603 KB

english, 2016

23

Single- and Multiple-Dose Pharmacokinetics of Levovirin Valinate Hydrochloride (R1518) in Healthy Volunteers

Huang, Yue, Ostrowitzki, Susanne, Hill, George, Navarro, Mercidita, Berger, Nancy, Kopeck, Paul, Mau, Cheng I., Alfredson, Tom, Lal, Ritu

Journal:

Journal of Clinical Pharmacology

Année:

2005

Langue:

english

Fichier:

PDF, 171 KB

english, 2005

24

CSF and amyloid pet biomarker data from scarlet road - a global Phase 3 study of gantenerumab in patients with prodromal AD

Nikolcheva, Tania, Lasser, Robert, Ostrowitzki, Susanne, Scheltens, Philip, Boada, Merce, Dubois, Bruno, Dorflinger, Ernest, Volz, Dietmar, Eichenlaub, Udo, Rabe, Christina, Bittner, Tobias, Schmitz,

Journal:

Neurobiology of Aging

Année:

2016

Langue:

english

Fichier:

PDF, 83 KB

english, 2016

25

Tau: From research to clinical development

Holtzman, David M., Carrillo, Maria C., Hendrix, James A., Bain, Lisa J., Catafau, Ana M., Gault, Laura M., Goedert, Michel, Mandelkow, Eckhard, Mandelkow, Eva-Maria, Miller, David S., Ostrowitzki, Su

Journal:

Alzheimer's & Dementia

Année:

2016

Langue:

english

Fichier:

PDF, 514 KB

english, 2016

26

First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers

Schenk, Dale B., Koller, Martin, Ness, Daniel K., Griffith, Sue G., Grundman, Michael, Zago, Wagner, Soto, Jay, Atiee, George, Ostrowitzki, Susanne, Kinney, Gene G.

Journal:

Movement Disorders

Année:

2016

Langue:

english

Fichier:

PDF, 436 KB

english, 2016

27

CLINICAL TRIAL DESIGN OF CREAD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP PHASE 3 STUDY TO EVALUATE CRENEZUMAB TREATMENT IN PATIENTS WITH PRODROMAL-TO-MILD ALZHEIMER’S DISEASE

Blaettler, Thomas, Smith, Janice, Smith, Jillian, Paul, Robert, Asnaghi, Veronica, Fuji, Reina, Quartino, Angelica, Honigberg, Lee, Rabbia, Michael A., Yule, Susan, Ostrowitzki, Susanne, Fontoura, Pau

Journal:

Alzheimer's & Dementia

Année:

2016

Langue:

english

Fichier:

PDF, 53 KB

english, 2016

28

SAFETY AND TOLERABILITY OF CRENEZUMAB IN MILD-TO-MODERATE AD PATIENTS TREATED WITH ESCALATING DOSES FOR UP TO 25 MONTHS

Asnaghi, Veronica, Lin, Helen, Hu, Nan, Smith, Jillian, Cho, William, Ostrowitzki, Susanne

Journal:

Alzheimer's & Dementia

Année:

2017

Langue:

english

Fichier:

PDF, 217 KB

english, 2017

29

Results from a phase 1b multiple ascending-dose study of PRX002/RG7935, an Anti-alpha-synuclein monoclonal antibody, in patients with Parkinson’s disease

Jankovic, J., Goodman, I., Safirstein, B., Schenk, D.B., Kinney, G.G., Koller, M., Ness, D.K., Griffith, S.G., Grundman, M., Soto, J., Ostrowitzki, S., Boess, F.G., Martin-Facklam, M., Quinn, J.F., Is

Journal:

Parkinsonism & Related Disorders

Année:

2018

Langue:

english

Fichier:

PDF, 54 KB

english, 2018

30

First in-human PET study of 3 novel tau radiopharmaceuticals: [ 11 C]RO6924963, [ 11 C]RO6931643, and [ 18 F]RO6958948

Wong, Dean F., Comley, Robert, Kuwabara, Hiroto, Rosenberg, Paul B., Resnick, Susan M, Ostrowitzki, Susanne, Vozzi, Cristina, Boess, Frank, Oh, Esther, Lyketsos, Constantine G., Honer, Michael, Gobbi,

Journal:

Journal of Nuclear Medicine

Année:

2018

Langue:

english

Fichier:

PDF, 2.64 MB

english, 2018

31

A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

Ostrowitzki, Susanne, Lasser, Robert A., Dorflinger, Ernest, Scheltens, Philip, Barkhof, Frederik, Nikolcheva, Tania, Ashford, Elizabeth, Retout, Sylvie, Hofmann, Carsten, Delmar, Paul, Klein, Gregory

Journal:

Alzheimer's Research & Therapy

Année:

2017

Langue:

english

Fichier:

PDF, 969 KB

english, 2017

32

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease

Jankovic, Joseph, Goodman, Ira, Safirstein, Beth, Marmon, Tonya K., Schenk, Dale B., Koller, Martin, Zago, Wagner, Ness, Daniel K., Griffith, Sue G., Grundman, Michael, Soto, Jay, Ostrowitzki, Susanne

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 423 KB

english, 2018

33

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

Ostrowitzki, Susanne, Lasser, Robert A., Dorflinger, Ernest, Scheltens, Philip, Barkhof, Frederik, Nikolcheva, Tania, Ashford, Elizabeth, Retout, Sylvie, Hofmann, Carsten, Delmar, Paul, Klein, Gregory

Journal:

Alzheimer's Research & Therapy

Année:

2018

Langue:

english

Fichier:

PDF, 250 KB

english, 2018

34

BASELINE CHARACTERICS FROM A PHASE 3 TRIAL OF CRENEZUMAB IN PRODROMAL TO MILD ALZHEIMER’S DISEASE (CREAD)

Lin, Helen, Ostrowitzki, Susanne, Sink, Kaycee M., Millar, Laurie, Warren, Francis, Smith, Jillian, Schneider, Andres, Fuji, Reina N., Quartino, Angelica, Mackey, Howard, Rabbia, Michael A., Yule, Sus

Journal:

Alzheimer's & Dementia

Année:

2018

Fichier:

PDF, 96 KB

2018

35

BASELINE CHARACTERICS FROM A PHASE 3 TRIAL OF CRENEZUMAB IN PRODROMAL TO MILD ALZHEIMER’S DISEASE (CREAD)

Lin, Helen, Ostrowitzki, Susanne, Sink, Kaycee M., Millar, Laurie, Warren, Francis, Smith, Jillian, Schneider, Andres, Fuji, Reina N., Quartino, Angelica, Mackey, Howard, Rabbia, Michael A., Yule, Sus

Journal:

Alzheimer's & Dementia

Année:

2018

Langue:

english

Fichier:

PDF, 96 KB

english, 2018

36

-Amyloid(1–42) CSF immunoassay in the CREAD (BN29552) study of crenezumab in prodromal-to-mild AD

Grimmer, T., Rabe, C., Navarro, M., Clayton, D., Manuilova, E., Peters, O., Eichenlaub, U., Smith, J., Ostrowitzki, S., Honigberg, L., Bittner, T.

Journal:

Clinical Neurophysiology

Année:

2019

Langue:

english

Fichier:

PDF, 48 KB

english, 2019

37

-Amyloid(1–42) CSF immunoassay in the CREAD (BN29552) study of crenezumab in prodromal-to-mild AD

Grimmer, T., Rabe, C., Navarro, M., Clayton, D., Manuilova, E., Peters, O., Eichenlaub, U., Smith, J., Ostrowitzki, S., Honigberg, L., Bittner, T.

Journal:

Clinical Neurophysiology

Année:

2019

Fichier:

PDF, 48 KB

2019

38

BASELINE CHARACTERISTICS FROM CREAD2: A PHASE III TRIAL OF CRENEZUMAB IN EARLY (PRODROMAL-TO-MILD) ALZHEIMER'S DISEASE

Sink, Kaycee, Warren, Francis, Smith, Jillian, Schneider, Andres, Fuji, Reina N., Quartino, Angelica, Mackey, Howard, Rabbia, Michael, Yule, Susan, Fontoura, Paulo, Doody, Rachelle, Ostrowitzki, Susan

Journal:

Alzheimer's & Dementia

Année:

2019

Langue:

english

Fichier:

PDF, 120 KB

english, 2019

39

BASELINE CHARACTERISTICS FROM CREAD2: A PHASE III TRIAL OF CRENEZUMAB IN EARLY (PRODROMAL-TO-MILD) ALZHEIMER'S DISEASE

Sink, Kaycee, Warren, Francis, Smith, Jillian, Schneider, Andres, Fuji, Reina N., Quartino, Angelica, Mackey, Howard, Rabbia, Michael, Yule, Susan, Fontoura, Paulo, Doody, Rachelle, Ostrowitzki, Susan

Journal:

Alzheimer's & Dementia

Année:

2019

Fichier:

PDF, 120 KB

2019

40

Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimerâs disease

Yoshida, Kenta, Moein, Anita, Bittner, Tobias, Ostrowitzki, Susanne, Lin, Helen, Honigberg, Lee, Jin, Jin Y., Quartino, Angelica

Journal:

Alzheimer's Research & Therapy

Année:

2020

Fichier:

PDF, 1.28 MB

2020

41

P32 Phase III studies of crenezumab in early (prodromal-to-mild) Alzheimers disease (CREAD/CREAD2): Biomarker results

Bittner, T., Duning, T., Rabe, C., Clayton, D., Quartino, A., Bohorquez, S. Sanabria, Hu, N., Rabbia, M., Shimizu, H., Eichenlaub, U., Smith, J., Honigberg, L., Selkoe, D.J., Ostrowitzki, S.

Journal:

Clinical Neurophysiology

Année:

2020

Fichier:

PDF, 89 KB

2020